Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Triamcinolone

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  3  Next»
    Study title: études cliniques ouvertes multicentriques ayant inclus des enfants et nourissons
    Active substance: ECONAZOLE AND TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 26357
    Study title: In vivo study of the release of triamcinolone acetonide from 3 diferent vehicles (9-78 yrs)
    Active substance: ECONAZOLE AND TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 26358
    Study title: New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Asilian A, Darougheh A, Shariati F. Dermatol Surg. July 1, 2006, 907-15
    Active substance: FLUOROURACIL
    Study summary document link (including results):
    View full study record
    Document reference: 28266
    Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A study of the safety and efficacy of RG 5029Y (triamcinolone acetonide) aqueous nasal spray in patients with perennial allergic rhinitis -Procaccini RL -24/02/1994
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46853
    Study title: Study the therapeutic action (control and prevention fo asthma attacks) and safety of Triamcinolone hexacetonide in 60 ambulatory patients exhibiting asthma, by means of a trial in which it would be compared with other steroids.Valdés
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 48965
    Study title: An open study to compare the clinical efficacy and tolerance of two sustained action corticosteroids in ORL manifestations.Larger (Publication Thérapeutique, No. 3 (Suppl.), Apr. 1979)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 48963
    Study title: An open study to investigate the clinical efficacy of Triamcinolone hexacetonide in diseases of the ear in children.Larras-Martenot (Les Cahier d´O.R.L. 14(4): 415-416, 1979)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 48964
    Study title: Clinical trial to investigate the efficacy of Lederspan.Gedda
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 48961
    Study title: Clinical trial to investigate the efficacy of Triamcinolone hexacetonide in patients with chronic articular reumatism.Kodama et al.
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 48962
    Study title: [Injections and local infiltrations of triamcinolone hexacetonide (Lederle) in rheumatology]. [Article in Spanish] De Usobiaga JL. Rev Esp Reum Enferm Osteoartic. 1970 Apr;13(6):349-59.
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 48960
    Study title: An open study to investigate the clinical efficacy and grade of pain relief in patients recieving Triamcinolone hexacetonide by intra-articular injections or paravertebral infusions.Bonilla
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 48959
    Study title: Publication in CES0506 - Lavin B - 30/06/2006 Comparative efficacy, safety, and effect on quality of life of triamcinolone acetonide and fluticasone propionate aqueous nasal sprays in patients with fall seeasonal allergic rhinitis - Gross - 2002 (Annals of allergy asthma & immunology 89; 1: 56-62, 2002)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46833
    Study title: Publication in Expert Report - Critical Evaluation - Banerji DD - 06/12/1999 An evaluation of the effects of beclomethasone dipropionate aqueous nasal spray on long-term groqth in children - Rachelefsky GS - 1998 (J. Allergy Clin. Immunol. 101: S236)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46834
    Study title: Publication in PSUR Long term safety and efficacy of triamcinolone acetonide aqueous nasal spray for the treatment of perennial allergic rhinitis - Koepke JW - 1997 (Allergy and Asthma Proc. 18: 33-37)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46835
    Study title: Publication in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 Short-term growth in children with allergic rhinitis treated with oral antihistamine, depot and intranasal glucocorticoids - Wolthers OD - 1993 (Acta Paediatr 82:635-640)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46836
    Study title: Publication in Rapport d'Expert sur la documentation clinique - Staudinger H - Update Dossier 24/03/1997 International Rhinitis Management Working Group. International Consensus Report on the Diagnosis and Management of Rhinitis - No Author - 1994 (Allergy 19:5-34)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46837
    Study title: Publication in Rapport d'Expert sur la documentation pharmaco-toxicologique - Roquet F - 15/08/1995 A thirty day comparison of the oral toxicity of CL 30,980 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b-hydroxy-16a,17a-(isopropylidenedioxy)-21-(tetrahydropyran-2-yloxy)- and CL 22,353 : 1,4-Pregnadiene-3,20-dione, 9a-fluoro-11b,21-dihydroxy-16a,17a-(isopropylidenedioxy)- in rats - Kanegis LA - 26/09/1960 (Safety Evaluation.studies. PR Volume 6, 2694-2726)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46838
    Study title: Publication in Response Document of MRP type II variation - Banerji D - 16/05/2000 A long-term (1 year) safety study of triamcinolone acetonide (TAA) HFA oral inhaler in asthmatic children - Weinberg EG - 1999 (European Respiratory Journal 14 (S30) abstract P361, p42s)
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46839
    Study title: Report in Expert Report - Critical Evaluation - Banerji DD - 06/12/1999 A phase III, single center, randomised, cross-over paediatric trial with Nasacort AQ nasal spray assessing short term growth in patients with allergic rhinitis - Kane R- 15/08/2007
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46840
    Study title: Report in Rapport d'Expert sur la documentation clinique - Braunstein GL - 17/11/1995 A controlled, double-blind study of WHR 5029 (triamcinolone acetonide nasal aerosol) and placebo in patients with perennial allergic rhinitis - No Author - No date
    Active substance: TRIAMCINOLONE
    Study summary document link (including results):
    View full study record
    Document reference: 46841
    1  2  3  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Feb 12 07:51:12 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA